With the Omicron surge waning – at least in the United States – there is speculation that the COVID-19 pandemic may be in its end stages, although some experts warn that this could be premature.
The Biden administration is seeking $30 billion in additional funds from Congress to fight the COVID-19 pandemic to bolster vaccines, treatments, testing supply and research, according to sources familiar with the matter.
The U.S. Senate on February 15 voted to confirm Dr. Robert Califf as commissioner of the U.S. Food and Drug Administration after some senators had argued his ties to the pharmaceutical industry or views on birth control made him unfit for the role.
More than one year after the first COVID-19 vaccination was administered in the United States and more than 545 million doses later, new data from a survey conducted online by The Harris Poll among over 2,000 U.S. adults on behalf of Ocugen Inc. show a majority of Americans want more COVID-19 vaccines options to choose from.
In concert with partner Senseonics Holdings, Ascensia Diabetes Care announced that the U.S. Food and Drug Administration signed off on the Eversense E3 Continuous Glucose Monitoring System (CGM) System.
Oxford University scientists said on February 15 they would evaluate the effects of new coronavirus variants on pregnant women and newborns, as well as COVID-19 vaccination effects on complications during pregnancy and after birth.
The World Health Organization indicated WHO is tracking four Omicron subvariants: BA.1, BA.1.1, BA.2 and BA.3. BA.2 has a growth advantage over BA.1, the variant responsible for the recent Omicron surge.
The latest wave of COVID-19 infections has “overwhelmed” Hong Kong, the city’s leader said on Feb. 14, as daily cases have surged by some 20 times over the past two weeks, leaving hospitals short of beds and struggling to cope. South Korea will begin giving out fourth doses of COVID-19 vaccines during February and supply millions of additional home test kits to ease shortages amid a surge in Omicron infections, authorities confirmed on Feb. 14.
Hong Kong reported a record 2,071 new daily COVID-19 infections on February 14 with 4,500 preliminary positive cases, authorities said, as the city battles to control a worsening outbreak.
Remember back in March and April and May of 2020, when people prefaced their plans for the future with, “When we get back to normal”? We never did, and we never will. The COVID experience has forever changed how all of us view the world, how we interact with each other … and, of course, how we interact with healthcare brands and what we expect from them. In seeking out insights from pharma’s wise heads for Med Ad News’ annual Agenda report, we tried to maneuver around COVID at least a little, to see what else was going on in the industry. But the plain fact is that we couldn’t, not really.